Molecular Partners AG Statistics
Share Statistics
Molecular Partners AG has 36.86M shares outstanding. The number of shares has increased by 1.03% in one year.
| Shares Outstanding | 36.86M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 36.76M |
| Failed to Deliver (FTD) Shares | 117 |
| FTD / Avg. Volume | 0.48% |
Short Selling Information
The latest short interest is 57.05K, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 57.05K |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.88% |
| Short Ratio (days to cover) | 1.69 |
Valuation Ratios
The PE ratio is -1.82 and the forward PE ratio is -3.09.
| PE Ratio | -1.82 |
| Forward PE | -3.09 |
| PS Ratio | 16.02 |
| Forward PS | 26.6 |
| PB Ratio | 0.64 |
| P/FCF Ratio | -1.88 |
| PEG Ratio | n/a |
Enterprise Valuation
Molecular Partners AG has an Enterprise Value (EV) of -68.07M.
| EV / Earnings | 1.1 |
| EV / Sales | -9.67 |
| EV / EBITDA | 1.14 |
| EV / EBIT | 1.11 |
| EV / FCF | 1.14 |
Financial Position
The company has a current ratio of 13.35, with a Debt / Equity ratio of 0.
| Current Ratio | 13.35 |
| Quick Ratio | 13.35 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -1247.1 |
Financial Efficiency
Return on equity (ROE) is -0.35% and return on capital (ROIC) is -33.93%.
| Return on Equity (ROE) | -0.35% |
| Return on Assets (ROA) | -0.31% |
| Return on Capital (ROIC) | -33.93% |
| Revenue Per Employee | 42.14K |
| Profits Per Employee | -371.16K |
| Employee Count | 167 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 23.52% in the last 52 weeks. The beta is 0.54, so Molecular Partners AG's price volatility has been higher than the market average.
| Beta | 0.54 |
| 52-Week Price Change | 23.52% |
| 50-Day Moving Average | 5.59 |
| 200-Day Moving Average | 5.28 |
| Relative Strength Index (RSI) | 46.14 |
| Average Volume (20 Days) | 24.13K |
Income Statement
In the last 12 months, Molecular Partners AG had revenue of $7.04M and earned -$61.98M in profits. Earnings per share was $-1.89.
| Revenue | 7.04M |
| Gross Profit | -40.81M |
| Operating Income | -61.11M |
| Net Income | -61.98M |
| EBITDA | -59.53M |
| EBIT | -61.11M |
| Earnings Per Share (EPS) | -1.89 |
Balance Sheet
The company has $67.31M in cash and $3.65M in debt, giving a net cash position of $63.66M.
| Cash & Cash Equivalents | 67.31M |
| Total Debt | 3.65M |
| Net Cash | 63.66M |
| Retained Earnings | -191.75M |
| Total Assets | 154.21M |
| Working Capital | 139.10M |
Cash Flow
In the last 12 months, operating cash flow was -$59.01M and capital expenditures -$808.00K, giving a free cash flow of -$59.81M.
| Operating Cash Flow | -59.01M |
| Capital Expenditures | -808.00K |
| Free Cash Flow | -59.81M |
| FCF Per Share | -1.83 |
Margins
Gross margin is -579.8%, with operating and profit margins of -868.26% and -880.7%.
| Gross Margin | -579.8% |
| Operating Margin | -868.26% |
| Pretax Margin | -880.7% |
| Profit Margin | -880.7% |
| EBITDA Margin | -845.84% |
| EBIT Margin | -868.26% |
| FCF Margin | -849.86% |
Dividends & Yields
MOLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -34.94% |
| FCF Yield | -29.99% |
Analyst Forecast
The average price target for MOLN is $4.5, which is -16.8% lower than the current price. The consensus rating is "Hold".
| Price Target | $4.5 |
| Price Target Difference | -16.8% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 5.61 |
| Piotroski F-Score | 2 |